Pharvaris Change To Netincome from 2010 to 2024

PHVS Stock  USD 22.36  1.81  7.49%   
Pharvaris Change To Netincome yearly trend continues to be comparatively stable with very little volatility. Change To Netincome is likely to outpace its year average in 2024. From the period from 2010 to 2024, Pharvaris Change To Netincome quarterly data regression had mean square error of 1.7 T and mean deviation of  550,332. View All Fundamentals
 
Change To Netincome  
First Reported
2010-12-31
Previous Quarter
576.1 K
Current Value
604.9 K
Quarterly Volatility
1.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Pharvaris financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharvaris' main balance sheet or income statement drivers, such as Tax Provision of 634.5 K, Net Interest Income of 223.4 K or Depreciation And Amortization of 54.6 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.41. Pharvaris financial statements analysis is a perfect complement when working with Pharvaris Valuation or Volatility modules.
  
Check out the analysis of Pharvaris Correlation against competitors.

Latest Pharvaris' Change To Netincome Growth Pattern

Below is the plot of the Change To Netincome of Pharvaris BV over the last few years. It is Pharvaris' Change To Netincome historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pharvaris' overall financial position and show how it may be relating to other accounts over time.
Change To Netincome10 Years Trend
Very volatile
   Change To Netincome   
       Timeline  

Pharvaris Change To Netincome Regression Statistics

Arithmetic Mean150,163
Coefficient Of Variation829.69
Mean Deviation550,332
Median103,714
Standard Deviation1,245,892
Sample Variance1.6T
Range6.4M
R-Value0.04
Mean Square Error1.7T
R-Squared0
Significance0.89
Slope10,538
Total Sum of Squares21.7T

Pharvaris Change To Netincome History

2024604.9 K
2023576.1 K
2022640.1 K
2021-3.5 M
20202.9 M
2019112.5 K

About Pharvaris Financial Statements

Pharvaris shareholders use historical fundamental indicators, such as Change To Netincome, to determine how well the company is positioned to perform in the future. Although Pharvaris investors may analyze each financial statement separately, they are all interrelated. The changes in Pharvaris' assets and liabilities, for example, are also reflected in the revenues and expenses on on Pharvaris' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Change To Netincome576.1 K604.9 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Pharvaris Stock Analysis

When running Pharvaris' price analysis, check to measure Pharvaris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharvaris is operating at the current time. Most of Pharvaris' value examination focuses on studying past and present price action to predict the probability of Pharvaris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharvaris' price. Additionally, you may evaluate how the addition of Pharvaris to your portfolios can decrease your overall portfolio volatility.